Retrospective analysis of severe COVID-19 pneumonia patients treated with lopinavir/ritonavir: A comparison with survivor and non-survivor patients

BACKGROUND: Currently there is no proven medical treatment for COVID-19. We aimed to determine the factors affecting mortality and changes in clinical and laboratory findings in patients with severe COVID-19 pneumonia treated with lopinavir/ritonavir (Lpv/r). METHODS: Data of survivor and non-surviv...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayten, Omer, Saylan, Bengu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378208/
https://www.ncbi.nlm.nih.gov/pubmed/34485485
http://dx.doi.org/10.4102/sajid.v35i1.233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378208/
https://www.ncbi.nlm.nih.gov/pubmed/34485485
http://dx.doi.org/10.4102/sajid.v35i1.233

Ejemplares similares